63페이지
——————————————————————-
Medicine Route of administration, dosage forms and strengths
——————————————————————-
1. Anaesthetics
1.1 General anaesthetics and oxygen
ether, anaesthetica inhalation
halothane inhalation
ketamine injection, 50 mg (as hydrochloride)/ml in 10ml vial
nitrous oxide inhalation
oxygen inhalation (medicinal gas)
thiopental powder for injection, 0.5 g, 1.0g (sodium salt) in ampoule
1.2 Local anaesthetics
bupivacaine injection, 0.25%, 0.5% (hydrochloride) in vial / injection for spinal anaesthesia, 0.5%(hydrochloride) in 4-ml ampoule to be mixed with 7.5% glucose solution
lidocaine injection, 1%, 2% (hydrochloride) in vial / injection for spinal anaesthesia, 5%(hydrochloride) in 2-ml ampoule to be mixed with 7.5% glucose solution / topical forms, 2–-4% (hydrochloride)
lidocaine + epinephrine injection, 1%, 2% (hydrochloride) +epinephrine 1 :200000 in vial
(adrenaline) dental cartridge, 2% (hydrochloride) +epinephrine 1 :80000
Complementary list medicine ephedrineb
injection, 30 mg (hydrochloride)/ml in 1ml ampoule
1.3 Preoperative medication and sedation for short-term procedures
atropine injection, 1 mg (sulfate) in 1-ml ampoule
diazepam injection, 5 mg/ml in 2-ml ampoule
tablet, 5mg
b For use in spinal anaesthesia during delivery, to prevent hypotension. Recommended of example within a pharmaceutical class.
64페이지
morphine injection, 10 mg (hydrochloride or sulfate) in 1ml ampoule
promethazine elixir or syrup, 5 mg (hydrochloride)/5ml
2. Analgesics, antipyretics, non-steroidal anti-inflammatory medicines, medicines used to treat gout and disease-modifying agents used in rheumatoid disorders
2.1 Non-opioid analgesics and antipyretics, and non-steroidal anti-inflammatory medicines
acetylsalicylic acid tablet, 100–-500mg / suppository, 50–-150mg
ibuprofen tablet, 200mg, 400mg
paracetamola tablet, 100–-500mg / suppository, 100mg / syrup, 125mg/5ml
2.2 Opioid analgesics
codeine tablet, 30mg (phosphate)
morphine injection, 10 mg (hydrochloride or sulfate) in 1-ml ampoule /
oral solution, 10 mg (hydrochloride or sulfate)/5ml / tablet, 10 mg (sulfate)
2.3 Medicines used to treat gout
allopurinol tablet, 100mg
colchicineb tablet, 500mg
2.4 Disease-modifying agents used in rheumatoid disorders
chloroquine tablet, 100mg, 150mg (as phosphate or sulfate)
a Not recommended for anti-inflammatory use due to lack of proven benefit to that effect.
65 페이지
azathioprine tablet, 50mg
methotrexate tablet, 2.5 mg (as sodium salt)
penicillamine capsule or tablet, 250mg
sulfasalazine tablet, 500mg
3. Antiallergics and medicines used in anaphylaxis
chlorphenamine tablet, 4mg(hydrogen maleate) /
injection, 10mg(hydrogen maleate) in 1ml ampoule
dexamethasone injection, 4mg dexamethasone phosphate (as disodium salt) in
1ml ampoule
epinephrine (adrenaline) injection, 1mg(as hydrochloride or hydrogen tartrate) in 1ml amp.
hydrocortisone powder for injection, 100mg (as sodium succinate) in vial
prednisolonea tablet, 5mg, 25mg
4. Antidotes and other substances used in poisonings
4.1 Non-specific
charcoal, activated powder
4.2 Specific
acetylcysteine injection, 200mg/ml in 10-ml ampoule
atropine injection, 1 mg (sulfate) in 1-ml ampoule
calcium gluconate injection, 100mg/ml in 10-ml ampoule
deferoxamine powder for injection, 500 mg (mesilate) in vial
dimercaprol injection in oil, 50mg/ml in 2-ml ampoule
DL-methionine tablet, 250mg
a no evidence for complete clinical similarity between prednisolone and dexamethasone at high doses.
66페이지
methylthioninium chloride(methylene blue) injection, 10 mg/ml in 10-ml ampoule
naloxone injection, 400mg (hydrochloride) in 1ml ampoule
penicillamine capsule or tablet, 250mg
potassium ferric hexacyano-ferrate(II)·2H2O (Prussian blue) powder for oral administration
sodium calcium edetate injection, 200 mg/ml in 5-ml ampoule
sodium nitrite injection, 30 mg/ml in 10-ml ampoule
sodium thiosulfate injection, 250 mg/ml in 50-ml ampoule
5. Anticonvulsants/antiepileptics
carbamazepine scored tablet, 100mg, 200mg
diazepam injection, 5 mg/ml in 2-ml ampoule (intravenous or rectal)
magnesium sulfatea injection, 500 mg/ml in 2-ml ampoule, 500mg/ml in 10-ml ampoule
phenobarbital tablet, 15–-100mg / elixir, 15mg/5ml
phenytoin capsule or tablet, 25mg, 50mg, 100mg (sodium salt) /
injection, 50 mg (sodium salt)/ml in 5-ml vial
valproic acid enteric coated tablet, 200mg, 500mg (sodium salt)
Complementary list medicines
clonazepamb scored tablet, 500mg
ethosuximide capsule, 250mg / syrup, 250mg/5ml
a For use in eclampsia and severe pre-eclampsia and not for other convulsant disorders.
67페이지
6. Anti-infective medicines
6.1 Anthelminthics
6.1.1 Intestinal anthelminthics
albendazole chewable tablet, 400mg
levamisole tablet, 50mg, 150mg (as hydrochloride)
mebendazole chewable tablet, 100mg, 500mg
niclosamidea chewable tablet, 500mg
praziquantel tablet, 150mg, 600mg
pyrantela chewable tablet, 250mg(as embonate) / oral suspension, 50mg(as embonate)/ml
6.1.2 Antifilarials
ivermectin scored tablet, 3mg, 6mg
Complementary list medicines
diethylcarbamazine tablet, 50mg, 100mg (dihydrogen citrate)
suramin sodium powder for injection, 1g in vial
6.1.3 Antischistosomals and other antitrematode medicines
praziquantel tablet, 600mg
triclabendazolea tablet, 250mg
Complementary list medicine
oxamniquinea capsule, 250mg / syrup, 250mg/5ml
6.2 Antibacterials
6.2.1 b-Lactam medicines
amoxicillin capsule or tablet, 250mg, 500mg(anhydrous) /
powder for oral suspension, 125mg(anhydrous)/5ml
68페이지
amoxicillin + clavulanic acida tablet, 500mg + 125mg
ampicillin powder for injection, 500mg, 1g (as sodium salt) in vial
benzathine benzylpenicillin powder for injection, 1.44g benzylpenicillin (= 2.4 million IU) in 5-ml vial
benzylpenicillin powder for injection, 600mg (= 1 million IU), 3g (= 5 million IU) (sodium or potassium salt) in vial
cloxacillin capsule, 500mg, 1g (as sodium salt) / powder for oral solution, 125mg (as
sodium salt)/5ml / powder for injection, 500mg (as sodium salt) in vial
phenoxymethylpenicillin tablet, 250 mg (as potassium salt)
powder for oral suspension, 250mg (as potassium salt)/5ml
procaine benzylpenicillin powder for injection, 1g (= 1 million IU), 3g (= 3 million IU) in vial
Complementary list medicines
ceftazidimea powder for injection, 250mg (as pentahydrate) in vial
ceftriaxonea powder for injection, 250mg (as sodium salt) in vial
imipenem + cilastatina,b powder for injection, 250mg (as monohydrate) + 250mg (as sodium
salt), 500 mg (as monohydrate) +500mg (as sodium salt) in vial
a Reserve antimicrobial for use only when there is significant resistance to other medicines on the Model List.
69페이지
6.2.2 Other antibacterials
azithromycina capsule, 250mg, 500mg / oral suspension, 200mg/5ml
chloramphenicol capsule, 250mg / oral suspension, 150 mg (as palmitate)/5ml
powder for injection, 1g (sodium succinate) in vial
oily suspension for injection, 0.5 g (as sodium succinate)/ml in 2-ml ampoule
ciprofloxacinb tablet, 250 mg (as hydrochloride)
doxycyclineb capsule or tablet, 100 mg (hydrochloride)
erythromycin capsule or tablet, 250 mg (as stearate or ethyl succinate)
powder for oral suspension, 125mg (as stearate or ethyl succinate)
powder for injection, 500mg (as lactobionate) in vial
gentamicinb injection, 10mg, 40mg (as sulfate)/ml in 2ml vial
metronidazole tablet, 200–-500mg / injection, 500 mg in 100-ml vial
suppository, 500mg, 1g / oral suspension, 200 mg (as benzoate)/5ml
nalidixic acidc tablet 250mg, 500mg
nitrofurantoin tablet, 100mg
a Only listed for single-dose treatment of genital Chlamydia trachomatis and of trachoma.
b Final selection depends on indication for use.
70페이지
spectinomycina powder for injection, 2g (as hydrochloride) in vial
sulfamethoxazole + trimethoprim tablet, 100mg+20mg, 400mg+80mg
oral suspension, 200mg + 40mg/5ml
injection, 80mg+16 mg/ml in 5ml ampoule, 80mg+16 mg/ml in 10ml ampoule
trimethoprim tablet, 100mg, 200mg
Complementary list medicines
clindamycin capsule, 150mg / injection, 150 mg (as phosphate)/ml
sulfadiazine tablet, 500mg / injection, 250 mg (sodium salt) in 4ml ampoule
vancomycinb powder for injection, 250mg (as hydrochloride) in vial
6.2.3 Antileprosy medicines(as multidrug therapy (MDT))
clofazimine capsule, 50mg, 100mg
dapsone tablet, 25mg, 50mg, 100mg
rifampicin capsule or tablet, 150mg, 300mg
6.2.4 Antituberculosis medicines
ethambutol tablet, 100–400 mg (hydrochloride)
b Reserve antimicrobial for use only when there is significant resistance to other medicines on the Model List.
71페이지
isoniazid tablet, 100–300mg
isoniazid + ethambutol tablet, 150mg+400mg
pyrazinamide tablet, 400mg
rifampicin capsule or tablet, 150mg, 300mg
rifampicin + isoniazid tablet, 60mg+30mg, 150mg+75mg, 300mg+150mg,
60mg+60mga, 150mg+150mga
rifampicin + isoniazid + pyrazinamide tablet, 60mg+30mg+150mg,
150mg+75mg+400mg, 150mg+150mg+500mga
rifampicin + isoniazid +pyrazinamide + ethambutol tablet, 150mg+75mg+400mg+275mg
streptomycin powder for injection, 1g (as sulfate) in vial
Complementary list medicines
amikacinb powder for injection, 1g in vial
p-aminosalicylic acidb tablet, 500mg / granules, 4g in sachet
capreomycinb powder for injection, 1g in vial
ciprofloxacinb tablet, 250mg, 500mg
cycloserineb capsule or tablet, 250mg
ethionamideb tablet, 125mg, 250mg
kanamycinb powder for injection, 1g in vial
levofloxacinb,c tablet, 250mg, 500mg
ofloxacinb tablet, 200mg, 400mg
a For intermittent use three times weekly.
b Reserve second-line medicine for the treatment of multidrug-resistant tuberculosis which should be used in specialized centres adhering to WHO standards for tuberculosis control.
72페이지
thioacetazone + isoniazid a tablet, 50mg+100mg, 150mg+300mg
6.3 Antifungal medicines
fluconazole capsule, 50mg / injection, 2 mg/ml in vial / oral suspension, 50mg/5ml
griseofulvin capsule or tablet, 125mg, 250mg
nystatin tablet, 100000IU, 500000IU / lozenge, 100000IU / pessary, 100000IU
Complementary list medicines
amphotericin B powder for injection, 50 mg in vial
flucytosine capsule, 250mg / infusion, 2.5 g in 250ml
potassium iodide saturated solution
6.4 Antiviral medicines
6.4.1 Antiherpes medicines
aciclovir tablet, 200mg / powder for injection, 250mg (as sodium salt) in vial
6.4.2 Antiretroviral medicines(다제요법)
73페이지
(a) Nucleoside reverse transcriptase inhibitors
abacavir (ABC) tablet, 300mg (as sulfate) / oral solution, 100mg (as sulfate)/5ml
didanosine (ddI) buffered chewable dispersible tablet, 25mg, 50mg, 100mg, 150mg, 200mg
buffered powder for oral solution, 100mg, 167mg, 250mg packets
unbuffered enteric coated capsule, 125mg, 200mg, 250mg, 400mg
lamivudine (3TC) tablet, 150mg / oral solution, 50mg/5ml
stavudine (d4T) capsule, 15mg, 20mg, 30mg, 40mg / powder for oral solution, 5mg/5ml
zidovudine (ZDV or AZT) capsule, 100mg, 250mg / oral solution or syrup, 50mg/5ml
tablet, 300mg / solution for IV infusion injection, 10mg/ml in 20ml vial
(b) Non-nucleoside reverse transcriptase inhibitors
efavirenz (EFV or EFZ) capsule, 50mg, 100mg, 200mg / oral solution, 150mg/5ml
nevirapine (NVP) tablet, 200mg / oral suspension, 50mg/5ml
(c) Protease inhibitors
74페이지
indinavir (IDV) capsule, 200mg, 333mg, 400mg (as sulfate)
lopinavir + ritonavir (LPV/r) capsule, 133.3mg+33.3mg / oral solution, 400mg+100mg/5ml
nelfinavir (NFV) tablet, 250 mg (as mesilate) / oral powder, 50mg/g
ritonavir (r) capsule, 100mg / oral solution, 400mg/5ml
saquinavir (SQV) capsule, 200mg
6.5 Antiprotozoal medicines
6.5.1 Antiamoebic and antigiardiasis medicines
diloxanide tablet, 500 mg (furoate)
metronidazole tablet, 200–500mg / injection, 500 mg in 100-ml vial
oral suspension, 200 mg (as benzoate)/5ml
6.5.2 Antileishmaniasis medicines
meglumine antimoniate injection, 30%, equivalent to approximately 8.1% antimony,
in 5ml ampoule
Complementary list medicines
amphotericin B powder for injection, 50mg in vial
pentamidine powder for injection, 200mg, 300mg(isetionate) in vial
6.5.3 Antimalarial medicines
(a) For curative treatment
Medicines for the treatment of P. falciparum malaria cases should be used in combination.
amodiaquinea tablet, 153mg, 200mg (base)
a Amodiaquine should preferably be used as part of combination therapy. Recommended example within a pharmaceutical class.
75페이지
artemether + lumefantrinea tablet, 20mg+120mg
chloroquine tablet, 100mg, 150mg (as phosphate or sulfate)
syrup, 50 mg (as phosphate or sulfate)/5ml
injection, 40 mg (as hydrochloride, phosphate or sulfate)/ml in 5ml ampoule
primaquine tablet, 7.5mg, 15mg (as diphosphate)
quinine tablet, 300 mg (as bisulfate or sulfate)
injection, 300 mg (as ihydrochloride)/ml in 2ml ampoule
Complementary list medicines
artemetherb injection, 80mg/ml in 1-ml ampoule
artesunateb tablet, 50mg
doxycyclinec capsule or tablet, 100 mg (hydrochloride)
mefloquine tablet, 250 mg (as hydrochloride)
sulfadoxine + pyrimethamine tablet, 500mg+25mg
(b) For prophylaxis
chloroquine tablet, 150mg(as phosphate or sulfate) /syrup, 50mg (as phosphate or sulfate)/5ml
doxycycline capsule or tablet, 100 mg (hydrochloride)
mefloquine tablet, 250 mg (as hydrochloride)
proguanild tablet, 100 mg (hydrochloride)
a Recommended for use in areas with significant drug resistance and not in pregnancy or in children below 10 kg.
b Reserve antimicrobial for use only when there is significant resistance to other medicines on the Model List.
c For use only in combination with quinine.
d For use only in combination with chloroquine.
76페이지
6.5.4 Antipneumocystosis and antitoxoplasmosis medicines
pyrimethamine tablet, 25mg
sulfamethoxazole + trimethoprim injection, 80mg+16mg/ml in 5ml ampoule,
80mg+16mg/ml in 10ml ampoule
Complementary list medicine
pentamidine tablet, 200mg, 300mg
6.5.5 Antitrypanosomal medicines
(a) African trypanosomiasis
melarsoprol injection, 3.6% solution
suramin sodium powder for injection, 1g in vial
Complementary list medicines
eflornithine injection, 200 mg (hydrochloride)/ml in 100ml bottle
pentamidine powder for injection, 200mg, 300mg(isetionate) in vial
(b) American trypanosomiasis
benznidazole tablet, 100mg
nifurtimox tablet, 30mg, 120mg, 250mg
6.6 Insect repellents
diethyltoluamidea topical solution, 50%, 75%
7. Antimigraine medicines
7.1 For treatment of acute attack
acetylsalicylic acid tablet, 300–500mg
ergotaminea tablet, 1 mg (tartrate)
paracetamol tablet, 300–500mg
77페이지
7.2 For prophylaxis
propranolol tablet, 20mg, 40mg (hydrochloride)
8. Antineoplastics, immunosuppressives and medicines used in palliative care
8.1 Immunosuppressive medicines
Complementary list medicines
azathioprine tablet, 50mg / powder for injection, 100mg (as sodium salt) in vial
ciclosporina capsule, 25mg / concentrate for injection, 50mg/ml in 1ml ampoule
8.2 Cytotoxic medicines
Complementary list medicines
asparaginase powder for injection, 10000IU in vial
bleomycin powder for injection, 15 mg (as sulfate) in vial
calcium folinate tablet, 15mg / injection, 3mg/ml in 10-ml ampoule
chlorambucil tablet, 2mg
chlormethine powder for injection, 10mg (hydrochloride) in vial
cisplatin powder for injection, 10mg, 50mg in vial
cyclophosphamide tablet, 25mg / powder for injection, 500 mg in vial
cytarabine powder for injection, 100 mg in vial
dacarbazine powder for injection, 100 mg in vial
dactinomycin powder for injection, 500mg in vial
daunorubicin powder for injection, 50mg (as hydrochloride)
a For organ transplantation.
78페이지
doxorubicin powder for injection, 10mg, 50mg(hydrochloride) in vial
etoposide capsule, 100mg / injection, 20 mg/ml in 5-ml ampoule
fluorouracil injection, 50 mg/ml in 5-ml ampoule
levamisole tablet, 50 mg (as hydrochloride)
mercaptopurine tablet, 50mg
methotrexate tablet, 2.5mg(as sodium salt)
powder for injection, 50mg(as sodium salt) in vial
procarbazine capsule, 50 mg (as hydrochloride)
vinblastine powder for injection, 10 mg (sulfate) in vial
vincristine powder for injection, 1mg, 5mg (sulfate) in vial
8.3 Hormones and antihormones
Complementary list medicines
dexamethasone injection, 4mg dexamethasone phosphate (as disodium salt) in 1ml ampoule
hydrocortisone powder for injection, 100mg (as sodium succinate) in vial
prednisolonea tablet, 5mg, 25mg
tamoxifen tablet, 10mg, 20mg (as citrate)
8.4 Medicines used in palliative care
The Committee recommended that all the medicines mentioned in the WHO publication, Cancer pain relief: with a guide to opioid availability, 2nd ed., be considered essential. The medicines are included in the relevant sections of the Model List, according to their therapeutic use, e.g. as analgesics.
a There is no evidence for complete clinical similarity between prednisolone and dexamethasone at high doses.
79페이지
9. Antiparkinsonism medicines
biperiden tablet, 2 mg (hydrochloride) / injection, 5 mg (lactate) in 1-ml ampoule
levodopa + carbidopa tablet, 100mg+10mg, 250mg+25mg
10. Medicines affecting the blood
10.1 Antianaemia medicines
ferrous salt tablet, equivalent to 60mg iron
oral solution, equivalent to 25 mg iron (as sulfate)/ml
ferrous salt + folic acida tablet, equivalent to 60 mg iron + 400mg folic acid
folic acid tablet, 1mg, 5mg
hydroxocobalamin injection, 1mg in 1-ml ampoule
10.2 Medicines affecting coagulation
heparin sodium injection, 1000 IU/ml, 5000 IU/ml, 20000IU/ml in 1-ml ampoule
phytomenadione injection, 10mg/ml in 5-ml ampoule / tablet, 10mg
protamine sulfate injection, 10mg/ml in 5-ml ampoule
warfarin tablet, 1mg, 2mg, 5mg (sodium salt)
11. Blood products and plasma substitutes
11.1 Plasma substitutes
dextran 70 injectable solution, 6%
polygelineb injectable solution, 3.5%
a Nutritional supplement for use during pregnancy.
80페이지
11.2 Plasma fractions for specific use
Complementary list medicines
factor VIII concentratea dried
factor IX complex (coagulation factors II, VII, IX, X) concentratea dried
12. Cardiovascular medicines
12.1 Antianginal medicines
atenolol tablet, 50mg, 100mg
glyceryl trinitrate tablet (sublingual), 500mg
isosorbide dinitrate tablet (sublingual), 5mg
verapamil tablet, 40mg, 80mg (hydrochloride)
12.2 Antiarrhythmic medicines
atenolol tablet, 50mg, 100mg
digoxin tablet, 62.5mg, 250mg / oral solution, 50mg/ml / injection, 250mg/ml in 2-ml ampoule
epinephrine (adrenaline) injection, 1 mg (as hydrochloride)/ml in ampoule
lidocaine injection, 20 mg (hydrochloride)/ml in 5-ml ampoule
verapamil tablet, 40mg, 80mg(hydrochloride)
injection, 2.5mg(hydrochloride)/ml in 2ml ampoule
Complementary list medicines
isoprenalinea injection, 20mg (hydrochloride)/ml in ampoule
procainamidea injection, 100 mg (hydrochloride)/ml in 10-ml ampoule
quinidinea tablet, 200 mg (sulfate)
81페이지
12.3 Antihypertensive medicines
atenolol tablet, 50mg, 100mg
enalapril tablet, 2.5mg
hydralazine tablet 25mg, 50mg (hydrochloride)
powder for injection, 20mg (hydrochloride) in ampoule
hydrochlorothiazide scored tablet, 25mg
methyldopaa tablet, 250mg
nifedipineb sustained-release formulations tablet, 10mg
Complementary list medicine
sodium nitroprusside powder for infusion, 50mg in ampoule
12.4 Medicines used in heart failure
digoxin tablet, 62.5mg, 250mg / oral solution, 50mg/ml / injection, 250mg/ml in 2ml ampoule
enalapril tablet, 2.5mg
hydrochlorothiazide scored tablet, 25mg
Complementary list medicine
dopamine injection, 40 mg (hydrochloride)/ml in 5-ml vial
12.5 Antithrombotic medicines
acetylsalicylic acid tablet, 100mg
Complementary list medicine
streptokinase powder for injection, 1.5 million IU in vial
a Methyldopa is listed for use in the management of pregnancy-induced hypertension only. Its use in the treatment of essential hypertension is not recommended in view of the availability of further evidence of the efficacy and safety of other medicines.
82페이지
12.6 Lipid-lowering agents(각 국가 사정에 맞게)
13. Dermatological medicines (topical)
13.1 Antifungal medicines
benzoic acid + salicylic acid ointment or cream, 6% + 3%
miconazole ointment or cream, 2% (nitrate)
sodium thiosulfate solution, 15%
Complementary list medicine
selenium sulfide detergent-based suspension, 2%
13.2 Anti-infective medicines
methylrosanilinium chloride(gentian violet) aqueous solution, 0.5% / tincture, 0.5%
neomycin + bacitracin ointment, 5mg neomycin sulfate + 500 IU bacitracin zinc/g
potassium permanganate aqueous solution, 1 :10000
silver sulfadiazine cream, 1% in 500g container
13.3 Anti-inflammatory and antipruritic medicines
betamethasone ointment or cream, 0.1% (as valerate)
calamine lotion lotion
hydrocortisone ointment or cream, 1% (acetate)
83페이지
13.4 Astringent medicines
aluminium diacetate solution, 13% for dilution
13.5 Medicines affecting skin differentiation and proliferation
benzoyl peroxide lotion or cream, 5%
coal tar solution, 5%
dithranol ointment, 0.1–2%
fluorouracil ointment, 5%
podophyllum resin solution, 10–25%
salicylic acid solution, 5%
urea ointment or cream, 10%
13.6 Scabicides and pediculicides
benzyl benzoate lotion, 25%
permethrin cream, 5% / lotion, 1%
13.7 Ultraviolet-blocking agents
Complementary list medicine
topical sun protection agent with activity against ultraviolet A and ultraviolet Ba
cream, lotion or gel
14. Diagnostic agents
14.1 Ophthalmic medicines
fluorescein eye drops, 1% (sodium salt)
tropicamide eye drops, 0.5%
14.2 Radiocontrast media
amidotrizoate injection, 140–420mg iodine(as sodium or meglumine salt)/ml in 20ml ampoule
84페이지
barium sulfate aqueous suspension
iohexol injection, 140–350mg iodine/ml in 5ml, 10ml or 20ml ampoule
iopanoic acid tablet, 500mg
propyliodone oily suspension, 500–-600 mg/ml in 20-ml ampoulea
Complementary list medicine
meglumine iotroxate solution, 5–8g iodine in 100–250ml
15. Disinfectants and antiseptics
15.1 Antiseptics
chlorhexidine solution, 5% (digluconate) for dilution
ethanol solution, 70% (denatured)
polyvidone iodine solution, 10%
15.2 Disinfectants
chlorine base compound powder (0.1% available chlorine) for solution
chloroxylenol solution, 4.8%
glutaral solution, 2%
16. Diuretics
amiloride tablet, 5 mg (hydrochloride)
furosemide tablet, 40mg / injection, 10 mg/ml in 2-ml ampoule
hydrochlorothiazide scored tablet, 25mg
mannitol injectable solution, 10%, 20%
spironolactone tablet, 25mg
a For administration only into the bronchial tree.
85페이지
17. Gastrointestinal medicines
17.1 Antacids and other antiulcer medicines
aluminium hydroxide tablet, 500mg / oral suspension, 320mg/5ml
magnesium hydroxide oral suspension, equivalent to 550mg magnesium oxide/10ml
ranitidine tablet, 150mg (as hydrochloride) / oral solution, 75mg/5ml
injection, 25mg/ml in 2ml ampoule
17.2 Antiemetic medicines
metoclopramide tablet, 10mg(hydrochloride) / injection, 5mg(hydrochloride)/ml in 2ml ampoule
promethazine tablet, 10mg, 25mg (hydrochloride) / elixir or syrup, 5 mg (hydrochloride)/5ml
injection, 25 mg (hydrochloride)/ml in 2-ml ampoule
17.3 Antihaemorrhoidal medicines
local anaesthetic, astringent and anti-inflammatory medicinea ointment or suppository
17.4 Anti-inflammatory medicines
sulfasalazine tablet, 500mg / suppository, 500mg / retention enema
Complementary list medicine
□hydrocortisoneb suppository, 25mg (acetate) / retention enema
b The square box symbol (□) applies only to hydrocortisone, retention enema.
86페이지
17.5 Antispasmodic medicines
atropinea tablet, 1 mg (sulfate) / injection, 1 mg (sulfate) in 1-ml ampoule
17.6 Laxatives
senna tablet, 7.5 mg (sennosides) (or traditional dosage forms)
17.7 Medicines used in diarrhoea
17.7.1 Oral hydration
oral rehydration salts (for powder, 20.5 g/l
glucose–electrolyte solution) Components (for 1 litre of glucose–electrolyte solution)b:
glucose 13.5g/l sodium chloride 2.6 g/l
potassium chloride 1.5 g/l trisodium citrate dihydratec 2.9 g/l
These components provide a glucose–elecrolyte solution with the following molar concentrations:
glucose 75mEq sodium 75mEq or mmol/l
chloride 65mEq or mmol/l potassium 20mEq or mmol/l
citrate 10mmol/l osmolarity 245mOsm/l
17.7.2 Antidiarrhoeal (symptomatic) medicines
codeinea tablet, 30mg (phosphate)
b In cases of cholera a higher concentration of sodium may be required.
c Trisodium citrate dihydrate may be replaced by sodium hydrogen carbonate (sodium bicarbonate) 2.5 g/l. However, as the stability of this latter formulation is very poor under tropical conditions, it is only recommended when manufactured for immediate use.
87페이지
18. Hormones, other endocrine medicines and contraceptives
18.1 Adrenal hormones and synthetic substitutes
Addison’’s disease is a rare condition; adrenal hormones for the treatment of this condition are already included in section 3.
18.2 Androgens
Complementary list medicine
testosterone injection, 200 mg (enantate) in 1-ml ampoule
18.3 Contraceptives
18.3.1 Hormonal contraceptives
ethinylestradiol + levonorgestrel tablet, 30mg + 150mg
ethinylestradiol + norethisterone tablet, 35mg + 1.0mg
levonorgestrel tablet, 30mg, 750mg (pack of two), 1.5mg
norethisterone enantate oily solution, 200mg/ml in 1-ml ampoule
Complementary list medicine
medroxyprogesterone acetatea depot injection, 150 mg/ml in 1-ml vial
18.3.2 Intrauterine devices
copper-containing device
18.3.3 Barrier methods
condoms
diaphragms
18.4 Estrogens
ethinylestradiol tablet, 10mg, 50mg
18.5 Insulins and other antidiabetic agents
glibenclamide tablet, 2.5mg, 5mg
insulin injection (soluble) injection, 40 IU/ml in 10ml vial, 100IU/ml in 10ml vial
88페이지
intermediate-acting insulin injection, 40 IU/ml in 10-ml vial, 100IU/ml in 10ml vial (as compound insulin zinc suspension or isophane insulin)
metformin tablet, 500 mg (hydrochloride)
18.6 Ovulation inducers
Complementary list medicine
clomifene tablet, 50 mg (citrate)
18.7 Progestogens
norethisterone tablet, 5mg
Complementary list medicine
medroxyprogesterone acetatea tablet, 5mg
18.8 Thyroid hormones and antithyroid medicines
levothyroxine tablet, 50mg, 100mg (sodium salt)
potassium iodide tablet, 60mg
propylthiouracil tablet, 50mg
19. Immunologicals
19.1 Diagnostic agents
tuberculin, purified protein derivative (PPD) injection
19.2 Sera and immunoglobulins
anti-D immunoglobulin (human) injection, 250mg in single-dose vial
89페이지
antitetanus immunoglobulin (human) injection, 500 IU in vial
antivenom seraa injection
diphtheria antitoxin injection, 10000IU, 20000IU in vial
rabies immunoglobulin injection, 150 IU/ml in vial
a Exact type to be defined locally.
90페이지
19.3 Vaccines
19.3.1 For universal immunization
BCG vaccine
diphtheria vaccine
hepatitis B vaccine
measles vaccine
pertussis vaccine
poliomyelitis vaccine
tetanus vaccine
19.3.2 For specific groups of individuals
influenza vaccine
meningococcal meningitis vaccine
mumps vaccine
rabies vaccine (inactivated) (prepared in cell culture)
rubella vaccine
typhoid vaccine
yellow fever vaccine
91페이지
20. Muscle relaxants (peripherally-acting) and cholinesterase inhibitors
alcuronium injection, 5 mg (chloride)/ml in 2-ml ampoule
neostigmine tablet, 15mg(bromide) / injection, 500mg, 2.5mg (metilsulfate) in 1ml ampoule
suxamethonium injection, 50 mg (chloride)/ml in 2-ml ampoule
powder for injection (chloride), in vial
Complementary list medicines
pyridostigmine tablet, 60mg (bromide) / injection, 1mg in 1-ml ampoule
vecuronium powder for injection, 10 mg (bromide) in vial
21. Ophthalmological preparations
21.1 Anti-infective agents
gentamicin solution (eye drops), 0.3% (as sulfate)
idoxuridine solution (eye drops), 0.1% / eye ointment, 0.2%
silver nitratea solution (eye drops), 1%
tetracycline eye ointment, 1% (hydrochloride)
21.2 Anti-inflammatory agents
prednisolone solution (eye drops), 0.5% (sodium phosphate)
21.3 Local anaesthetics
tetracaine solution (eye drops), 0.5% (hydrochloride)
92페이지
21.4 Miotics and antiglaucoma medicines
acetazolamide tablet, 250mg
pilocarpine solution (eye drops), 2%, 4% (hydrochloride or nitrate)
timolol solution (eye drops), 0.25%, 0.5% (as maleate)
21.5 Mydriatics
atropine solution (eye drops), 0.1%, 0.5%, 1% (sulfate)
Complementary list medicine
epinephrine (adrenaline) solution (eye drops), 2% (as hydrochloride)
22. Oxytocics and antioxytocics
22.1 Oxytocics
ergometrinea tablet, 200mg (hydrogen maleate)
injection, 200mg (hydrogen maleate) in 1ml ampoule
oxytocin injection, 10 IU in 1-ml ampoule
22.2 Antioxytocics
salbutamola tablet, 4 mg(as sulfate) / injection, 50mg (as sulfate)/ml in 5ml ampoule
23. Peritoneal dialysis solution
Complementary list medicine
intraperitoneal dialysis solution (of appropriate composition) parenteral solution
93페이지
24. Psychotherapeutic medicines
24.1 Medicines used in psychotic disorders
chlorpromazine tablet, 100mg (hydrochloride) / syrup, 25mg (hydrochloride)/5ml
injection, 25mg (hydrochloride)/ml in 2ml ampoule
fluphenazine injection, 25mg (decanoate or enantate) in 1ml ampoule
haloperidol tablet, 2mg, 5mg injection, 5mg in 1ml ampoule
24.2 Medicines used in mood disorders
24.2.1 Medicines used in depressive disorders
amitriptyline tablet, 25mg (hydrochloride)
24.2.2 Medicines used in bipolar disorders
carbamazepine scored tablet, 100mg, 200mg
lithium carbonate capsule or tablet, 300mg
valproic acid enteric coated tablet, 200mg, 500mg(sodium salt)
24.3 Medicines used in generalized anxiety and sleep disorders
diazepam scored tablet, 2mg, 5mg
24.4 Medicines used in obsessive–-compulsive disorders and panic attacks
clomipramine capsule, 10mg, 25mg (hydrochloride)
25. Medicines acting on the respiratory tract
25.1 Antiasthmatics and medicines for chronic obstructive pulmonary disease
beclometasone inhalation (aerosol), 50mg, 250mg (dipropionate) per dose
epinephrine (adrenaline) injection, 1 mg (as hydrochloride or
hydrogen tartrate) in 1-ml ampoule
ipratropium bromide inhalation (aerosol), 20mg/metered dose
94페이지
salbutamol tablet, 2mg, 4mg (as sulfate) / inhalation (aerosol), 100mg (as sulfate) per dose
syrup, 2 mg (as sulfate)/5ml / injection, 50mg (as sulfate)/ml in 5-ml ampoule
respirator solution for use in nebulizers, 5mg (as sulfate)/ml
theophyllinea tablet, 100mg, 200mg, 300mg
Complementary list medicines
aminophyllinea injection, 25 mg/ml in 10-ml ampoule
cromoglicic acid a inhalation (aerosol), 20 mg (sodium salt) per dose
26. Solutions correcting water, electrolyte and acid–-base disturbances
26.1 Oral
oral rehydration salts (for glucose–electrolyte solution) For composition, see section 17.7.1
potassium chloride powder for solution
26.2 Parenteral
glucose injectable solution, 5%, 10% isotonic, 50% hypertonic
glucose with sodium chloride injectable solution, 4% glucose, 0.18% sodium chloride (equivalent to Na+ 30mmol/l, Cl- 30mmol/l)
potassium chloride solution, 11.2% in 20-ml ampoule
(equivalent to K+ 1.5mmol/ml, Cl- 1.5mmol/ml)
sodium chloride injectable solution, 0.9% isotonic
(equivalent to Na+ 154mmol/l, Cl- 154mmol/l)
95페이지
sodium hydrogen carbonate injectable solution, 1.4% isotonic (equivalent to
Na+ 167mmol/l, HCO3- 167mmol/l), 8.4% (equivalent to Na+ 1000mmol/l, HCO3- 1000mmol/l) in 10-ml ampoule
sodium lactate, compound solution injectable solution
26.3 Miscellaneous
water for injection 2ml, 5ml, 10ml ampoules
27. Vitamins and minerals
ascorbic acid tablet, 50mg
ergocalciferol capsule or tablet, 1.25mg (50000IU) / oral solution, 250mg/ml (10000IU/ml)
iodine capsule, 200mg / iodized oil, 1ml (480 mg iodine), 0.5ml (240 mg iodine) in ampoule (oral or injectable), 0.57 ml (308 mg iodine) in dispenser bottle
nicotinamide tablet, 50mg
pyridoxine tablet, 25 mg (hydrochloride)
retinol capsule, 200000IU (as palmitate) (110mg)
sugar-coated tablet, 10000IU (as palmitate) (5.5mg)
oral oily solution, 100000IU (as palmitate)/ml in multidose dispenser water-miscible injection, 100000IU (as palmitate) (55 mg) in 2-ml ampoule
riboflavin tablet, 5mg
96페이지
sodium fluoridea in any appropriate formulation
thiamine tablet, 50 mg (hydrochloride)
Complementary list medicine
calcium gluconatea injection, 100 mg/ml in 10-ml ampoule
